IMNM
IMNM
NASDAQ · Biotechnology

Immunome Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$22.44
+0.25 (+1.13%)
As of May 9, 9:36 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +486.0% upside
Low Target $82.08
Average Target $131.49
High Target $141.61
Current Price $22.44
Current
$22.44
Target
$131.49
$82.08 $131.49 avg $141.61
Scenario Analysis
Bear Case
$82.08
265.8%
Low target
Base Case
$131.49
+486.0%
Avg target
Bull Case
$141.61
+531.1%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$27.65
-18.8% from high
52-Week Low
$7.15
+213.8% from low
50-Day SMA
$22.49
-0.2% vs SMA
200-Day SMA
$14.32
+56.7% vs SMA
RSI (14)
37.4
Neutral
Target vs 52W High
$131.49
+375.6% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.57
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%